1. Home
  2. CERS vs HRZN Comparison

CERS vs HRZN Comparison

Compare CERS & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • HRZN
  • Stock Information
  • Founded
  • CERS 1991
  • HRZN 2008
  • Country
  • CERS United States
  • HRZN United States
  • Employees
  • CERS N/A
  • HRZN N/A
  • Industry
  • CERS EDP Services
  • HRZN Finance/Investors Services
  • Sector
  • CERS Technology
  • HRZN Finance
  • Exchange
  • CERS Nasdaq
  • HRZN Nasdaq
  • Market Cap
  • CERS 276.0M
  • HRZN 275.7M
  • IPO Year
  • CERS 1997
  • HRZN 2010
  • Fundamental
  • Price
  • CERS $1.69
  • HRZN $6.61
  • Analyst Decision
  • CERS Buy
  • HRZN Hold
  • Analyst Count
  • CERS 1
  • HRZN 4
  • Target Price
  • CERS $4.00
  • HRZN $7.44
  • AVG Volume (30 Days)
  • CERS 1.3M
  • HRZN 742.5K
  • Earning Date
  • CERS 11-06-2025
  • HRZN 10-28-2025
  • Dividend Yield
  • CERS N/A
  • HRZN 20.12%
  • EPS Growth
  • CERS N/A
  • HRZN N/A
  • EPS
  • CERS N/A
  • HRZN N/A
  • Revenue
  • CERS $199,191,000.00
  • HRZN $98,899,000.00
  • Revenue This Year
  • CERS $19.07
  • HRZN $0.85
  • Revenue Next Year
  • CERS $12.03
  • HRZN $9.80
  • P/E Ratio
  • CERS N/A
  • HRZN N/A
  • Revenue Growth
  • CERS 13.03
  • HRZN N/A
  • 52 Week Low
  • CERS $1.12
  • HRZN $5.71
  • 52 Week High
  • CERS $2.24
  • HRZN $9.99
  • Technical
  • Relative Strength Index (RSI)
  • CERS 59.26
  • HRZN 55.05
  • Support Level
  • CERS $1.47
  • HRZN $6.35
  • Resistance Level
  • CERS $1.78
  • HRZN $6.60
  • Average True Range (ATR)
  • CERS 0.13
  • HRZN 0.16
  • MACD
  • CERS 0.01
  • HRZN -0.01
  • Stochastic Oscillator
  • CERS 78.75
  • HRZN 50.48

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

Share on Social Networks: